Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Biocon receives CRL from US FDA over cancer treatment biosimilar

expressbpdOctober 12, 2017

Tag: Biocon , CRL , US FDA

PharmaSources Customer Service